Copertina

A Multisite Fusion‐Based Deep Convolutional Neural Network for Classification of Helicobacter pylori Infection Status Using Endoscopic Images: A Multicenter Study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Duwei Dai, Xiaojing Quan, Yueqin Zheng, Yu Wang, Quan Hao, Yali Lei, Yuan Gao, Jianqun Liang, Hanhua Zhang, Yun Huang, Changxin Chen, Jia Wang, Jiantao Zhang, Jie Wu, Baicang Zou, Lu Li, Haitao Shi, Bin Qin
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Journal of Gastroenterology and Hepatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Helicobacter pylori Infection and Cholelithiasis
di: Evangelos Kazakos, et al.
Pubblicazione: (2024)

Asia‐Pacific Survey on the Management of Helicobacter pylori Infection
di: Koji Otani, et al.
Pubblicazione: (2024)

A Potential Impact of Helicobacter pylori Infection on Gastroesophageal Reflux Disease
di: Jannis Kountouras, et al.
Pubblicazione: (2026)

Management of Helicobacter pylori Infection: Do We Completely See Eye to Eye?
di: Vaneet Jearth
Pubblicazione: (2025)

Letter to the Editor Regarding “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”
di: Parena Maheshwari
Pubblicazione: (2025)

Revolution of Helicobacter pylori treatment
di: Yoshio Yamaoka
Pubblicazione: (2024)

Management of Tunnel Infection Following Upper Gastrointestinal Endoscopic Submucosal Tunneling Procedures
di: Shao‐Bin Luo, et al.
Pubblicazione: (2025)

Response to the Letter by Dr. Parena Maheshwari Regarding Our Manuscript, “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”
di: Koji Otani, et al.
Pubblicazione: (2025)

Helicobacter pylori and Porphyromonas gingivalis Infections as Potential Risk Predictors for Gastric Cancer and Two Types of Esophageal Cancer
di: Jannis Kountouras, et al.
Pubblicazione: (2026)

Fourteen‐and Ten‐Day Tegoprazan–Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for Helicobacter pylori Eradication—A Noninferiority, Multicenter, Randomized Controlled Trial
di: Yan Fan, et al.
Pubblicazione: (2025)

Protective or Perplexing? Rethinking the Helicobacter pylori –GERD Relationship
di: Qin Xiang Ng, et al.
Pubblicazione: (2025)

Relationship between Helicobacter pylori infection, osteoporosis, and fracture
di: Jing Tong Tan, et al.
Pubblicazione: (2024)

Noninferiority of 14‐THA for Helicobacter pylori Eradication: Reconsidering the Evidence
di: Wenjun Jiang
Pubblicazione: (2026)

Feasibility and Safety of Endoscopic Full‐Thickness Resection for Gastric Submucosal Tumors With Extraluminal Growth
di: Shao‐Bin Luo, et al.
Pubblicazione: (2025)

Randomized Comparison of Vonoprazan–Amoxicillin Dual Therapy Versus Bismuth Quadruple Therapies for Helicobacter pylori Eradication: A Multicenter Trial Evaluating National Centralized Drug Procurement Antibiotics
di: Youyu Cheng, et al.
Pubblicazione: (2025)

Comment on: “Long‐Term Outcomes of Surveillance Endoscopy After Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Study”
di: Fang Wang
Pubblicazione: (2026)

Genomic analysis of Helicobacter pylori in Australia: Antimicrobial resistance, phylogenetic patterns, and virulence factors
di: Jonathon P Schubert, et al.
Pubblicazione: (2024)

Helicobacter pylori and metabolic syndrome‐related adipokines in nonalcoholic fatty liver disease pathophysiology
di: J Kountouras, et al.
Pubblicazione: (2024)

Evaluating vonoprazan bismuth‐containing triple therapy versus quadruple therapy for Helicobacter pylori
di: W‐Z Tang, et al.
Pubblicazione: (2024)

“Comment on: Efficacy and Safety of Semisynthetic Tetracycline Containing Quadruple Therapy for Helicobacter pylori Eradication”
di: Amina Riaz, et al.
Pubblicazione: (2026)

Antibiotic Resistance in Helicobacter pylori in the Asia‐Pacific Region: A Call for Coordinated Regional Strategies
di: Koji Otani, et al.
Pubblicazione: (2025)

Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence
di: Fumiaki Ishibashi, et al.
Pubblicazione: (2024)

Safety and Efficacy of Submucosal Tunneling Endoscopic Septum Division for Esophageal Diverticulum
di: Zi‐Han Geng, et al.
Pubblicazione: (2025)

Assessment and Management of Reflux‐Related Esophageal Stricture After Peroral Endoscopic Myotomy in Achalasia
di: Shao‐Bin Luo, et al.
Pubblicazione: (2025)

Efficacy and safety of tegoprazan‐ and rabeprazole‐based concomitant therapies for Helicobacter pylori infection: Real‐world evidence
di: Byung Wook Jung, et al.
Pubblicazione: (2024)

Mechanism, Association, and Actionable Evidence: Comment on Engin et al. on Helicobacter pylori and Extra‐Gastric Cancer Risk
di: Shaher Yar, et al.
Pubblicazione: (2026)

Helicobacter pylori Screening and Eradication in Junior High School Students in Yokosuka, Japan: Prevalence, Eradication Rates, and Challenges
di: Yoshika Saito, et al.
Pubblicazione: (2025)

Ten vs. 14 Days of Vonoprazan‐Based Therapy for Helicobacter pylori : Systematic Review and Meta‐Analysis of Randomized Trials
di: Tareq Alsaleh, et al.
Pubblicazione: (2026)

Prevalence and Incidence of Gastric Cancer Among Helicobacter pylori –Naïve Individuals in Japan: A Systematic Review and Meta‐Analysis
di: Chikamasa Ichita, et al.
Pubblicazione: (2025)

Helicobacter pylori and Metabolic Syndrome‐Related Mast Cells May Be Potential Risk Factors for the Increased Prevalence of Barrett's Esophagus
di: Jannis Kountouras, et al.
Pubblicazione: (2025)

Comparison of vonoprazan bismuth‐containing triple therapy with quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: a prospective multicenter randomized controlled trial
di: Jing Wen Liang, et al.
Pubblicazione: (2024)

Endoscopic Ultrasound–Guided Gastrojejunostomy as a Primary Treatment Modality for Malignant Gastric Outlet Obstruction: A Large Multicenter Experience
di: Nikhil Sonthalia, et al.
Pubblicazione: (2025)

Effects of Successful Versus Delayed/Failed Helicobacter pylori Eradication Therapy on Subsequent Fracture Risk: a Population‐Based Cohort Study
di: Jing Tong Tan, et al.
Pubblicazione: (2026)

Comparative efficacy of Helicobacter pylori eradication therapy between tegoprazan‐based concomitant and bismuth quadruple therapies: A real‐world evidence
di: Yoon Suk Jung, et al.
Pubblicazione: (2024)

Long‐Term Outcomes of Surveillance Endoscopy After Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Study
di: Akira Dobashi, et al.
Pubblicazione: (2026)

Role of Virtual Ruler‐Based Diameter Measurement in Endoscopic Therapy for Cirrhotic Esophageal Varices: A Retrospective Multicenter Study
di: Zhongliang Fang, et al.
Pubblicazione: (2024)

Underwater Endoscopic Mucosal Resection for Early Gastric Cancer: An Endoscopic Treatment Method Worthy of Study
di: Yi‐Heng Yao, et al.
Pubblicazione: (2025)

Tip‐In Underwater Endoscopic Mucosal Resection for Superficial Nonampullary Duodenal Epithelial Tumors ≤ 20 mm: An Endoscopic Technology Worthy of Promotion
di: Zhu‐Lin Ying, et al.
Pubblicazione: (2025)

Comment on “ Helicobacter pylori Screening and Eradication in Junior High School Students in Yokosuka, Japan: Prevalence, Eradication Rates, and Challenges” (J Gastroenterol Hepatol 2025; 40:2499–2506)
di: Hiroshi Nishida
Pubblicazione: (2026)

Advanced Endoscopic Techniques
Pubblicazione: (2024)